Objective
"Advanced designed vaccines have to combine proper antigen with the effective immune-stimulating agents (adjuvants) and delivery strategies in order to attain successful treatment. Presently, most vaccines are given as liquid formulations by intramuscular administration. However, nano-sized carriers of antigens hold great promise to be more effective delivery systems. To achieve the desired anti-cancer therapy; the ideal antigen nano-carrier has to fulfil a number of requirements. First of all carriers need to be (hollow) particles like with diameters in the range 50-500 nm in order to be taken up by dendritic cells (antigen-presenting cells capable to induce immune response). To facilitate the development of cellular immune responses, vaccine antigen must be presented on MHC (Major Histocompatibility Complex) class I. To win the goal, the nano-carrier should selectively bind to these cells, and be taken up into endosomes. To doing this carriers should be able to display certain adjuvants as targeting and stimulating ligands on their surface, and be capable to release its cargo upon response to pH changes in the endosome. Furthermore, vesicles have to carry and release antigen (i.e. proteins) to target destination with minor side-effects (biocompatibility and non-toxicity of carrier are essential). Hence, it is the goal of proposed project to develop nano-carriers on the basis of block copolymer vesicles (polymersomes) that have all those features.
The aim is to developed polymersomes based on amphiphilic poly(2-methyloxazoline) PMOXA or (polydimethysiloxane) PDMS blocks in combination with stimulus-responsive copolymers blocks and a tunable polymersome surface chemistry.
Therefore, the final goal is to provide ""smart"" drug delivery system with versatile surface chemistry, which will allow the attachment/incorporation of different adjuvants (e.g. saponins) and consequently enable target delivery."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2011-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
4051 Basel
Switzerland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.